| Document |
Document Title |
|
WO/2024/060698A1 |
Provided is use of Staphylococcus lentus with an accession number of GDMCC 1.247 in preparing a composition for preventing or treating symptoms of insulin resistance or type 2 diabetes. The strain can significantly reduce the weight gain...
|
|
WO/2024/060701A1 |
Disclosed in the present invention is a method for removing extracellular antibiotic resistance genes in water, which belongs to the field of environmental management. The method involves adding a cell lysate, especially a cell lysate of...
|
|
WO/2024/064752A2 |
Bio-adhesive derived from Vibrio cholerae (Vc) are provided. In some forms, the bio-adhesive includes a sequence of 57 amino acids within a major biofilm adhesin Bap1, and sequence variations thereof, that can be used as bioactive glue t...
|
|
WO/2024/063404A1 |
The present invention relates to a method for cultivating a botulinum toxin-producing strain to increase botulinum toxin productivity and to a method for effectively producing botulinum toxin by culturing a strain using the method. Throu...
|
|
WO/2024/062471A1 |
Botanical extracts are provided, which comprise ethanol extracts of Nannochloropsis algae having between 10wt% and 50wt% polar lipids and between 45wt% and 60wt% fatty acids, wherein the fatty acids comprise more than 10wt% of eicosapent...
|
|
WO/2024/059578A2 |
Disclosed are biomass compositions comprising microbial cells such as yeast cells engineered to express a heme-containing protein, and their use in the preparation of various food compositions.
|
|
WO/2024/059489A1 |
Methods, sample vessels, and instruments are provided for determining susceptibility of a bacterium to one or more classes of antibiotics.
|
|
WO/2024/058182A1 |
This transformed microorganism of a microorganism belonging to the genus Cupriavidus, which has the ability to produce a copolyester of 3-hydroxybutyric acid and another hydroxyalkanoic acid, has: a gene encoding a copolyester synthase; ...
|
|
WO/2024/058613A1 |
The present invention relates to novel Azospirillum sp. FWR9 (KACC 81197BP), which is good for use in compost preparation, and compost using same. Azospirillum sp. FWR9 (KACC 81197BP) of the present invention degrades high molecular weig...
|
|
WO/2024/057297A1 |
The invention relates to Bacillus sp. strain UAACBES 01L isolated from the leaves of the Surian [Toona sinensis (Juss,) M.Roem], which has potential as a bioreductor (biological reducing agent) in the green biosynthesis of zinc oxide nan...
|
|
WO/2024/059180A1 |
Phenotypic screening methods that can be used for the screening of nitrogen fixation activity in bacteria are described herein. Such screening methods utilize a plurality of partitions comprising soil that allow for cost effective and ef...
|
|
WO/2024/058155A1 |
The present invention addresses the problem of providing a new method for simply and efficiently producing linear covalently closed DNA. Provided is a double stranded circular DNA vector, wherein the double stranded circular DNA vector...
|
|
WO/2024/056638A1 |
The present invention relates to a method for producing a stable hydrogel-cell composition comprising the steps of: a) providing a reaction mixture comprising at least one polymerizable substrate and at least one enzyme capable of polyme...
|
|
WO/2024/058612A1 |
The present invention relates to a novel Neorizobium sp. Neorhizobium sp.) FWR7 (KACC 81196BP) suitable for use in compost production, and compost using same. The Neorizobium sp. Neorhizobium sp.) FWR7 (KACC 81196BP) of the present inven...
|
|
WO/2024/058198A1 |
Provided is a production method which is for induced pluripotent stem cells and by which induced pluripotent stem cells having high undifferentiation properties and differentiation potency are easily obtained. A production method for i...
|
|
WO/2024/059251A1 |
A method of scavenging carbon dioxide and/or metabolic waste and producing oxygen and- or metabolic products includes forming a scaffold, device from a nano to microporous material such that the scaffold device defines an interior chambe...
|
|
WO/2024/058255A1 |
The purpose of the present invention is to provide an agent for adjusting cytokine production by lipopolysaccharide derived from Escherichia coli, or an agent for adjusting TLR4 activation by lipopolysaccharide derived from Escherichia c...
|
|
WO/2024/056081A1 |
Provided are bifidobacterium breve B51 and B280, a product thereof, and use thereof. The bifidobacterium breve is B51 or B280. The B51 is collected in China General Microbiological Culture Collection Center of China Committee for Culture...
|
|
WO/2024/059274A2 |
Disclosed herein is a transportable bio-cement comprising a desiccated microorganism package; where the microorganism package comprises one or more microorganisms; a first binder, where the first binder is produced by the microorganism; ...
|
|
WO/2024/059718A1 |
Disclosed herein, are compositions comprising bacterial strains from Clostridia or Bacilli, and methods of treating obesity, metabolic syndrome, inflammatory bowel disease, as well as reducing weight gain, inhibiting lipid absorption in ...
|
|
WO/2024/056027A1 |
The present invention provides use of an ldh gene-containing lactobacillus plantarum in preparing a product for relieving enteritis. The lactobacillus plantarum or plasmid involved in the present invention is an ldh gene-containing lacto...
|
|
WO/2024/057907A1 |
The purpose of the present invention is to provide a rotifer feed and a production method of a rotifer feed that reduce the burden of contamination control during culture. The rotifer feed (YFU3 strain concentrate feed F) contains a micr...
|
|
WO/2024/059139A2 |
A genetically modified E. coli bacterium is provided where the bacterium expresses a microbial anti-inflammatory molecule (MAM) protein. In one embodiment, the bacterium is a probiotic. In another embodiment, the bacterium is modified is...
|
|
WO/2024/055616A1 |
Provided is a Bacillus sp. strain X102, which was preserved in the Guangdong Microbial Culture Collection Center on June 9, 2022, with a preservation number of GDMCC No: 62531. The Bacillus sp. strain has bacteriostatic effects on gram-n...
|
|
WO/2024/055988A1 |
Provided are an isolated polypeptide consisting of a mutant B domain of Protein A, an unnatural immunoglobulin binding protein containing the mutant B domain, a conjugate containing the mutant B domain or the unnatural immunoglobulin bin...
|
|
WO/2024/055735A1 |
Provided are a genetically engineered bacterium with high yield of gibberellin acid GA 3, a construction method, and use. By means of enhanced expression of a gene expressing cytochrome P450 reductase CPR and a gene encoding vitreoscilla...
|
|
WO/2024/059851A1 |
Some aspects of this invention provide engineered microbes for oil production. Methods for microbe engineering and for use of engineered microbes are also provided herein. In some embodiments, microbes provided are engineered to produce ...
|
|
WO/2024/050590A1 |
The present invention provides compositions comprising microbial biomass and one or more branched chain fatty acids, as well as food products, beverage products or feedstuffs comprising microbial biomass and one or more branched chain fa...
|
|
WO/2024/050588A1 |
The present invention provides compositions comprising microbial biomass, and food products, beverage products or feedstuffs comprising microbial biomass. Desribed herein are the uses of said compositions and food products, beverage prod...
|
|
WO/2024/054979A1 |
The present disclosure is directed to a genetic construct for performing loopable translation, a kit comprising the genetic construct, and a method of producing biomaterials comprising a highly repetitive protein by use of the genetic co...
|
|
WO/2023/081837A9 |
Provided are methods, prokaryotic host cells, expression vectors, and kits for the production of a tryptophan, a tryptamine, or an intermediate or a side product thereof, or a derivative thereof. In some embodiments, the tryptophan, tryp...
|
|
WO/2024/054673A1 |
Embodiments of the present disclosure pertain to a modified Listeria monocytogenes bacterium (Listeria) that is associated with at least one therapeutic agent. The therapeutic agent may be associated with a surface of the Listeria throug...
|
|
WO/2024/053406A1 |
Research on methods for selective differentiation induction from pluripotent stem cells to small intestine epithelium-like cells is underway. The present invention provides an excellent highly functional small intestine epithelium-like c...
|
|
WO/2024/054921A2 |
The present disclosure relates to microorganisms useful in the biosynthesis of psicose. Also provided are methods of producing the disclosed microorganism and methods of producing psicose.
|
|
WO/2024/052546A1 |
The present invention relates to modified bacteria of the species Yersinia entomophaga which are useful to produce toxins and pesticides such as insecticides. The present invention further relates to a toxin composition and a purified in...
|
|
WO/2024/055027A2 |
Provided are modified bacteria, compositions comprising the modified bacteria and Rare Earth Elements (REEs), and method of using the modified bacteria to separate REEs from a variety of materials and liquids.
|
|
WO/2024/050928A1 |
Disclosed in the present invention is a method for preparing pyrrolidone. Provided in the present invention is a method for preparing pyrrolidone from γ-aminobutyric acid under the catalysis of carnitine-CoA ligase CaiC. The amino acid ...
|
|
WO/2024/053519A1 |
Disclosed are a kit for diagnosing Alzheimer's disease and a pharmaceutical composition for treating Alzheimer's disease that use EDIL3 or a nucleic acid that encodes EDIL3 as an indicator or a target.
|
|
WO/2024/051151A1 |
Provided is high-efficiency silicon-releasing Streptomyces CS13-6, with an accession number of CGMCC No. 25523. The bacterial strain has relatively high silicon release, phosphate solubilization and potassium mobilization, nitrogen fixat...
|
|
WO/2024/053984A1 |
The present invention relates to a recombinant Saccharomyces boulardii capable of metabolizing L-fucose, a sugar derived from intestinal mucin. The present invention provides a genetically engineered Saccharomyces boulardii that metaboli...
|
|
WO/2024/051249A1 |
The present application provides a lysophosphatidylcholine acyltransferase for improving an EPA content, a nucleic acid molecule, and use thereof. Provided is a lysophosphatidylcholine acyltransferase (PtLPCAT) from Phaeodactylum tricorn...
|
|
WO/2024/053719A1 |
One purpose of the present invention is to provide an antibody against coronavirus (SARS-CoV-2) variants. Another purpose of the present invention is to provide a medicinal composition against coronavirus infections, the composition bein...
|
|
WO/2024/055019A1 |
Provided are methods and systems for detection of oral bacteria.
|
|
WO/2024/050591A1 |
The present invention provides a method of producing a composition capable of producing a food-like aroma and/or flavour when heated, comprising a) disrupting a Mortierella spp. biomass comprising phospholipids; b) fractionating the disr...
|
|
WO/2024/052901A1 |
The present application, provides, inter alia, a composition including an esterified fatty acid, including a fatty acid comprising 4 to 24 carbon atoms, for use in a method for prevention or treatment of a monogenean infection in an aqua...
|
|
WO/2024/051268A1 |
A polycyclic aromatic hydrocarbons (PAHs) contaminated soil remediation agent based on the mechanism of plant-microbe combined action and a preparation method therefor and a use thereof. The soil remediation agent is biochar fixedly adso...
|
|
WO/2024/050589A1 |
The present invention provides compositions comprising microbial biomass, one or more lactones and/or one or more 4-hydroxy fatty acids, as well as food products, beverage products or feedstuffs comprising microbial biomass, one or more ...
|
|
WO/2024/054959A1 |
The present disclosure provides a soil carbon inoculum granular formulation comprising: a) a carbon sequestering fungal strain; b) a solid carrier selected from the group consisting of cellulose, a non-viable grain, a non-viable seed, a ...
|
|
WO/2024/046489A1 |
Provided are a cutinase mutant and the use thereof in the efficient degradation of PET. The amino acid sequence of the cutinase mutant is as shown in SEQ ID NO.2, where phenylalanine at position 239 of the amino acid sequence of the wild...
|
|
WO/2024/050288A2 |
A microbial platform for rare earth element bioaccumulation comprises a bacterial culture, a medium comprising methanol, inorganic phosphate, and a swarf pulp, wherein the platform is selective for bioaccumulation of a rare earth element.
|
